Allison Rowland
Family · Louisville, KYNPI 1790044774
Payments from drug & device makers
Across 387 payments — averaging $18.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$844
- Biohaven Pharmaceuticals, Inc.$794
- AstraZeneca$684
- Pfizer$659
- GSK$405
- Biohaven Pharmaceutical Holding Company Ltd.$379
- plus $3K from 32 others
What the payments were for
- Food & beverage$6,965100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 65 | $844 |
| Biohaven Pharmaceuticals, Inc. | 16 | $794 |
| AstraZeneca | 28 | $684 |
| Pfizer | 57 | $659 |
| GSK | 33 | $405 |
| Biohaven Pharmaceutical Holding Company Ltd. | 19 | $379 |
| Johnson & Johnson | 19 | $353 |
| Lilly USA, LLC | 19 | $350 |
| Bayer | 8 | $222 |
| Boehringer Ingelheim | 15 | $213 |
| Novo Nordisk | 12 | $197 |
| Novartis | 10 | $177 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $176 |
| Exact Sciences | 10 | $174 |
| Phathom Pharmaceuticals, Inc. | 12 | $157 |
| Dexcom, Inc. | 3 | $146 |
| Esperion Therapeutics, Inc. | 7 | $115 |
| Axsome Therapeutics, Inc. | 1 | $113 |
| Merck | 6 | $106 |
| Amgen | 6 | $99 |
| Corcept Therapeutics | 5 | $85 |
| Boston Scientific | 3 | $69 |
| Xeris Pharmaceuticals, Inc. | 3 | $52 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Surgenex LLC | 1 | $46 |
| Abbott | 3 | $43 |
| Sanofi Pasteur Inc. | 2 | $43 |
| E.r. Squibb & Sons, L.L.C. | 3 | $40 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Neuronetics, Inc. | 1 | $21 |
| Mylan Specialty L.p. | 1 | $19 |
| Seqirus USA Inc | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Masimo Corporation | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$567
- BREZTRI$125
- MOUNJARO$125
- Auvelity$113
- DEXCOM G7 GSS (161)$106
How this compares
$6,965 in reported general payments places this provider in the 95th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 33 | $34,162 |
| EliquisApixaban | 27 | $33,748 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $29,535 |
| JardianceEmpagliflozin | 28 | $27,840 |
| OzempicSemaglutide | 29 | $27,024 |
| FarxigaDapagliflozin Propanediol | 27 | $20,627 |
| XareltoRivaroxaban | 16 | $18,748 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $16,044 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 265 | $4,047 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $3,420 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 76 | $3,001 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,936 |
| Novolog FlexpenInsulin Aspart | 18 | $2,886 |
| Atorvastatin Calcium | 249 | $2,152 |
| Lisinopril | 330 | $1,894 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $106 | $34,16233 claims |
| PfizerEliquis | $659 | $33,74827 claims |
| Boehringer IngelheimJardiance | $213 | $27,84028 claims |
| Novo NordiskOzempic | $197 | $27,02429 claims |
| AstraZenecaFarxiga, Symbicort | $684 | $23,56339 claims |
| Johnson & JohnsonXarelto | $353 | $18,74816 claims |
| GSKTrelegy Ellipta | $405 | $16,04419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,374 family providers in Kentucky.
Other family in Louisville
- Smita RanjanLouisville$92K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Shelley WaldmanLouisville$59K
- Esther MuhsLouisville$44K
- Barbra CaveLouisville$41K
- Kayla WilsonLouisville$40K
- Christin ThompsonLouisville$38K
- Wendi HallerLouisville$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.